Human recombinant SLAMF7 (from HEK293)
- Protein/Peptid-Typ:Rekombinant
- Ursprung:HEK293 cells
- Spezies:Human
- Lagerbedingungen:–20 °C
- Endotoxingehalt:Less than 1,0 EU per μg by the LAL method.
- Biologische Aktivität:Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Humanized Anti-Human CS1 MAb at 1 μg/ml (100 µl/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag with a linear range of 0,6-5 ng/ml (Routinely tested).; 2e5 of Anti-SLAMF7 CAR-293 cells were stained with 100 µl of 0,1 μg/ml of Biotinylated Human SLAMF7, Avitag, His Tag and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).
- Gen-ID:Q9NQ25-1
- Frei von Trägern:Y
- Frei von Proteasen:Y
- Tierfrei:Y
- Proteinsynonym:FOAP-12|CRACC|19A|CS1|CD319|SLAMF7
- Protein/Peptid-Name:SLAMF7
- Purity:>95%
- Molecular weight:25,6 kDa
- Endotoxinspiegel:Low
- Zusammensetzung:Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.
- Frei von Nukleasen:Y
- Transporttemperatur:Powder,RT
Frequently Bought Together